Following an abbreviated submission
follitropin alfa 150 IU/ lutropin alfa 75 IU solution for injection (Pergoveris®) is accepted for use within NHS Scotland for stimulation of follicular development in women with severe LH and FSH deficiency. In clinical trials, these patients were defined by an endogenous serum LH level <1.2 IU/l.
It may be used in cases where the use of both of these agents, at the doses provided by this formulation, is appropriate.
Download detailed advice28KB (PDF)
- Medicine name:
- follitropin alpha/lutropin alpha (Pergoveris)
- SMC ID:
- stimulation of follicular development in women with severe LH and FSH deficiency
- Pharmaceutical company
- Merck Serono Ltd
- BNF chapter
- Endocrine system
- Submission type
- Date advice published
- 10 March 2008